SUN COAST SCIENCES, LLC – Trademark Portfolio
Entity Type: 16
SUN COAST SCIENCES, LLC holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 13 trademarks are registered and 2 are pending. Notable registered marks include AMPALIVE, VITALIFI, REJUVALUX, SKIN SALT, and VITACELL+. The owner is based in CHEYENNE, WY.
1603 CAPITOL AVENUE
SUITE 310 A401
CHEYENNE, WY 82001
Showing of trademarks Trademarks
Trademark Classifications
SUN COAST SCIENCES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does SUN COAST SCIENCES, LLC have?
SUN COAST SCIENCES, LLC has 18 U.S. trademarks filed with the USPTO. Of these, 13 registered, 2 pending, 3 abandoned.
What trademark classes does SUN COAST SCIENCES, LLC file in?
SUN COAST SCIENCES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SUN COAST SCIENCES, LLC's most well-known trademarks?
SUN COAST SCIENCES, LLC's registered trademark portfolio includes well-known marks such as AMPALIVE, VITALIFI, REJUVALUX, SKIN SALT, and VITACELL+. These are among 13 currently registered trademarks in the portfolio.
What is SUN COAST SCIENCES, LLC's trademark registration success rate?
SUN COAST SCIENCES, LLC has a 81% trademark registration rate, with 13 out of 16 resolved applications resulting in successful registration. Currently, 2 applications are pending review.